合計 50 件の最近のインサイダー取引記録が記録されています Cabaletta Bio, Inc. (CABA), 内訳は 37 件の買い および 12 件の売り. インサイダー買い総額は $32.42M インサイダー売り総額は $15.88M.
最近活動のある主要インサイダーには Nichtberger Steven, Marda Anup, Chang David J.. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — CABA
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-02 |
Nichtberger Steven |
President & CEO |
RSU 付与（制限付株式） |
674,000 |
$3.30 |
$2.22M |
674,000 |
| 2026-03-02 |
Marda Anup |
Chief Financial Officer |
RSU 付与（制限付株式） |
225,000 |
$3.30 |
$742.5K |
225,000 |
| 2026-03-02 |
Chang David J. |
Chief Medical Officer |
RSU 付与（制限付株式） |
225,000 |
$3.30 |
$742.5K |
225,000 |
| 2026-03-02 |
Binder Gwendolyn |
President, Science & Tech. |
RSU 付与（制限付株式） |
225,000 |
$3.30 |
$742.5K |
225,000 |
| 2026-03-02 |
Gerard Michael |
General Counsel |
RSU 付与（制限付株式） |
175,000 |
$3.30 |
$577.5K |
175,000 |
| 2026-03-02 |
Das Arun |
Chief Business Officer |
RSU 付与（制限付株式） |
175,000 |
$3.30 |
$577.5K |
175,000 |
| 2026-01-21 |
Simon Mark |
Director |
情報に基づく買い |
11,061 |
$2.28 |
$25.26K |
147,205 |
| 2026-01-21 |
Nichtberger Steven |
President & CEO |
情報に基づく買い |
45,000 |
$2.24 |
$100.78K |
1,031,483 |
| 2026-01-21 |
Tomasello Shawn |
Director |
情報に基づく買い |
22,725 |
$2.21 |
$50.32K |
22,725 |
| 2026-01-21 |
Bollard Catherine |
Director |
情報に基づく買い |
4,405 |
$2.27 |
$9.98K |
5,405 |
| 2026-01-21 |
Chang David J. |
Chief Medical Officer |
情報に基づく買い |
8,800 |
$2.26 |
$19.89K |
8,800 |
| 2026-01-21 |
Binder Gwendolyn |
President, Science & Tech. |
情報に基づく買い |
11,312 |
$2.19 |
$24.76K |
31,312 |
| 2026-01-21 |
Gerard Michael |
General Counsel |
情報に基づく買い |
6,600 |
$2.27 |
$14.98K |
6,600 |
| 2026-01-21 |
Gavel Steve |
Chief Commercial Officer |
情報に基づく買い |
22,170 |
$2.27 |
$50.22K |
22,170 |
| 2025-10-13 |
Gavel Steve |
Officer |
不明 |
- |
- |
- |
- |
| 2025-10-13 |
Gavel Steve |
Chief Commercial Officer |
RSU 付与（制限付株式） |
275,000 |
$2.49 |
$684.75K |
275,000 |
| 2025-06-09 |
Henriques Richard C Jr |
Director |
RSU 付与（制限付株式） |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Simon Mark |
Director |
RSU 付与（制限付株式） |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Tomasello Shawn |
Director |
RSU 付与（制限付株式） |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Bollard Catherine |
Director |
RSU 付与（制限付株式） |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-06-09 |
Brun Scott C. |
Director |
RSU 付与（制限付株式） |
22,000 |
$2.37 |
$52.14K |
22,000 |
| 2025-05-19 |
Henriques Richard C Jr |
Director |
株式返還 |
22,000 |
$11.18 |
$245.96K |
- |
| 2025-05-19 |
Simon Mark |
Director |
株式返還 |
22,000 |
$10.01 |
$220.22K |
- |
| 2025-05-19 |
Nichtberger Steven |
President & CEO |
株式返還 |
411,600 |
$11.09 |
$4.56M |
- |
| 2025-05-19 |
Tomasello Shawn |
Director |
株式返還 |
44,000 |
$13.48 |
$593.12K |
- |
| 2025-05-19 |
Marda Anup |
Chief Financial Officer |
株式返還 |
130,000 |
$23.97 |
$3.12M |
- |
| 2025-05-19 |
Bollard Catherine |
Director |
株式返還 |
22,000 |
$10.01 |
$220.22K |
- |
| 2025-05-19 |
Chang David J. |
Chief Medical Officer |
株式返還 |
150,000 |
$11.09 |
$1.66M |
- |
| 2025-05-19 |
Binder Gwendolyn |
President, Science & Tech. |
株式返還 |
130,000 |
$23.97 |
$3.12M |
- |
| 2025-05-19 |
Brun Scott C. |
Director |
株式返還 |
22,000 |
$10.01 |
$220.22K |
- |
| 2025-05-19 |
Gerard Michael |
General Counsel |
株式返還 |
75,000 |
$3.21 |
$240.75K |
- |
| 2025-05-19 |
Das Arun |
Chief Business Officer |
株式返還 |
150,000 |
$11.09 |
$1.66M |
- |
| 2025-03-03 |
Nichtberger Steven |
President & CEO |
RSU 付与（制限付株式） |
450,000 |
$1.67 |
$751.5K |
450,000 |
| 2025-03-03 |
Marda Anup |
Chief Financial Officer |
RSU 付与（制限付株式） |
145,000 |
$1.67 |
$242.15K |
145,000 |
| 2025-03-03 |
Chang David J. |
Chief Medical Officer |
RSU 付与（制限付株式） |
145,000 |
$1.67 |
$242.15K |
145,000 |
| 2025-03-03 |
Binder Gwendolyn |
President, Science & Tech. |
RSU 付与（制限付株式） |
145,000 |
$1.67 |
$242.15K |
145,000 |
| 2025-03-03 |
Gerard Michael |
General Counsel |
RSU 付与（制限付株式） |
115,000 |
$1.67 |
$192.05K |
115,000 |
| 2025-03-03 |
Das Arun |
Chief Business Officer |
RSU 付与（制限付株式） |
115,000 |
$1.67 |
$192.05K |
115,000 |
| 2024-06-03 |
Henriques Richard C Jr |
Director |
RSU 付与（制限付株式） |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Simon Mark |
Director |
RSU 付与（制限付株式） |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Tomasello Shawn |
Director |
RSU 付与（制限付株式） |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Bollard Catherine |
Director |
RSU 付与（制限付株式） |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-06-03 |
Brun Scott C. |
Director |
RSU 付与（制限付株式） |
22,000 |
$10.01 |
$220.22K |
22,000 |
| 2024-03-01 |
Nichtberger Steven |
President & CEO |
RSU 付与（制限付株式） |
353,000 |
$23.97 |
$8.46M |
353,000 |
| 2024-03-01 |
Marda Anup |
Chief Financial Officer |
RSU 付与（制限付株式） |
130,000 |
$23.97 |
$3.12M |
130,000 |
| 2024-03-01 |
Chang David J. |
Chief Medical Officer |
RSU 付与（制限付株式） |
130,000 |
$23.97 |
$3.12M |
130,000 |
| 2024-03-01 |
Binder Gwendolyn |
See Remarks |
RSU 付与（制限付株式） |
130,000 |
$23.97 |
$3.12M |
130,000 |
| 2024-03-01 |
Gerard Michael |
General Counsel |
RSU 付与（制限付株式） |
100,000 |
$23.97 |
$2.4M |
100,000 |
| 2024-03-01 |
Das Arun |
Chief Business Officer |
RSU 付与（制限付株式） |
100,000 |
$23.97 |
$2.4M |
100,000 |
| 2024-01-19 |
Binder Gwendolyn |
See Remarks |
情報に基づく売り |
700 |
$20.33 |
$14.23K |
20,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
